Jeremiah Hadwen

Prolactin increases SMN expression and survival in a mouse model of severe spinal muscular atrophy via the STAT5 pathway

Faraz Farooq, Francisco Abadía Molina, Jeremiah Hadwen et al. · Journal of Clinical Investigation · 2011 · 81 citations · Full text

Sclerostin, Cytoskeleton, Progressive Muscle Atrophy +16

Celecoxib increases SMN and survival in a severe spinal muscular atrophy mouse model via p38 pathway activation

Faraz Farooq, Francisco Abadía‐Molina, Duncan S. MacKenzie et al. · Human Molecular Genetics · 2013 · 59 citations · Full text

Knockout Mouse, Neurodegenerative Diseases, Celecoxib Treatment +14

Mining the transcriptome for rare disease therapies: a comparison of the efficiencies of two data mining approaches and a targeted cell-based drug screen

Alan J. Mears, Sarah Schock, Jeremiah Hadwen et al. · npj Genomic Medicine · 2017 · 15 citations · Full text

VPAC2 receptor agonist BAY 55-9837 increases SMN protein levels and moderates disease phenotype in severe spinal muscular atrophy mouse models

Jeremiah Hadwen, Duncan S. MacKenzie, Fahad Shamim et al. · Orphanet Journal of Rare Diseases · 2014 · 14 citations · Full text

Sodium Channel Inhibitors Reduce DMPK mRNA and Protein

Luke Witherspoon, Sean O’Reilly, Jeremiah Hadwen et al. · Clinical and Translational Science · 2015 · 12 citations

Molecular Pharmacology, Inhibitory Activity, Signal Transduction +15